chr1-112918054-C-CAATA
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_003051.4(SLC16A1):c.362-11_362-10insTATT variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0064 ( 5 hom., cov: 0)
Exomes 𝑓: 0.0026 ( 2 hom. )
Consequence
SLC16A1
NM_003051.4 splice_polypyrimidine_tract, intron
NM_003051.4 splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.497
Genes affected
SLC16A1 (HGNC:10922): (solute carrier family 16 member 1) The protein encoded by this gene is a proton-linked monocarboxylate transporter that catalyzes the movement of many monocarboxylates, such as lactate and pyruvate, across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect. Alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Oct 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 1-112918054-C-CAATA is Benign according to our data. Variant chr1-112918054-C-CAATA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 1336772.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00643 (930/144614) while in subpopulation AFR AF= 0.0102 (395/38742). AF 95% confidence interval is 0.00937. There are 5 homozygotes in gnomad4. There are 476 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 SD gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC16A1 | NM_003051.4 | c.362-11_362-10insTATT | splice_polypyrimidine_tract_variant, intron_variant | ENST00000369626.8 | NP_003042.3 | |||
SLC16A1 | NM_001166496.2 | c.362-11_362-10insTATT | splice_polypyrimidine_tract_variant, intron_variant | NP_001159968.1 | ||||
SLC16A1 | XM_047428789.1 | c.362-11_362-10insTATT | splice_polypyrimidine_tract_variant, intron_variant | XP_047284745.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC16A1 | ENST00000369626.8 | c.362-11_362-10insTATT | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_003051.4 | ENSP00000358640 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00644 AC: 931AN: 144542Hom.: 5 Cov.: 0
GnomAD3 genomes
AF:
AC:
931
AN:
144542
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000856 AC: 52AN: 60732Hom.: 0 AF XY: 0.000813 AC XY: 29AN XY: 35678
GnomAD3 exomes
AF:
AC:
52
AN:
60732
Hom.:
AF XY:
AC XY:
29
AN XY:
35678
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00256 AC: 1830AN: 714864Hom.: 2 Cov.: 0 AF XY: 0.00250 AC XY: 904AN XY: 361898
GnomAD4 exome
AF:
AC:
1830
AN:
714864
Hom.:
Cov.:
0
AF XY:
AC XY:
904
AN XY:
361898
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00643 AC: 930AN: 144614Hom.: 5 Cov.: 0 AF XY: 0.00678 AC XY: 476AN XY: 70210
GnomAD4 genome
AF:
AC:
930
AN:
144614
Hom.:
Cov.:
0
AF XY:
AC XY:
476
AN XY:
70210
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | SLC16A1: BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 11, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at